According to the CITIC Securities Research Report, the medical and aesthetic industry is currently in a stage of rapid increase in upstream registration certificates, and competition is fierce, but structural opportunities persist: differentiated new product dividends still exist, and upstream brands with strong comprehensive capabilities such as marketing acquisition, medical promotion, product portfolio, and channel operation are expected to win the competition. Downstream has significantly benefited from changes in the industrial chain pattern, and downstream brands that can consolidate their reputation, reduce customer acquisition costs, provide comprehensive solutions, and increase gross margins are expected to continue to increase their share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.